创新服务于人类健康
Sihuanpharm (sihuanpharm.com) earns a Brand Analyzer score of 34 out of 100, placing it in the Early Stage tier among Healthcare brands. Among 2305 Healthcare brands analyzed, Sihuanpharm ranks in the 0th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 82/100, Digital Presence 14/100, Visual Identity 77/100, Messaging Clarity 53/100, Trust Foundation 20/100, AI Discoverability 24/100, Brand Authority 10/100.
Sihuanpharm (四环医药控股集团) is a Chinese pharmaceutical company focused on the cardiovascular and cerebrovascular drug market. Guided by the principles of dedication, focus, and professionalism, the company emphasizes innovation in service of human health. It possesses substantial research and development capabilities, a quality product portfolio, and a comprehensive production management system, operating with a distinctive marketing model and specialized services within China's healthcare sector.
| Brand Name | Sihuanpharm |
|---|---|
| Domain | sihuanpharm.com |
| Industry | Healthcare |
| Main Competitors | CSPC Pharmaceutical Group, Shenwei Pharmaceutical, Tasly Pharmaceutical, Buchang Pharmaceuticals, Yangtze River Pharmaceutical, Rongsheng Pharmaceutical |
Moz Domain Authority 33/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "以专心、专注、专业、共赢的企业精神，践行创新服务于人类健康的企业使命。发展至今，四环医药控股集团已拥有雄厚的研发实力、优质的产品结构、完善的生产管理体系，并以独特的营销模式和专业化的服务，深耕中国心脑血管药物市场领域，赢得了社会各界和专家用户的广泛赞誉，树立了" (Meta description too short (1 words). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Instagram; no detected presence on X (Twitter), LinkedIn, Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Sihuanpharm scores 13/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Sihuanpharm has a weak AI-visibility profile at 13/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (32/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 33/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Sihuanpharm's main competitors include CSPC Pharmaceutical Group, Shenwei Pharmaceutical, Tasly Pharmaceutical, Buchang Pharmaceuticals, Yangtze River Pharmaceutical. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Sihuanpharm official site
Popular alternatives to Sihuanpharm include CSPC Pharmaceutical Group, Shenwei Pharmaceutical, Tasly Pharmaceutical, Buchang Pharmaceuticals, Yangtze River Pharmaceutical. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Sihuanpharm official site
Sihuanpharm has low AI-search visibility, scoring 13/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 15, recommendation 32). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Sihuanpharm official site
Sihuanpharm and CSPC Pharmaceutical Group are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Sihuanpharm official site
Sihuanpharm scores 32/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Sihuanpharm official site
Sihuanpharm can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Sihuanpharm official site
Sihuanpharm (四环医药控股集团) is a Chinese pharmaceutical holding group that operates in the healthcare industry with a focus on innovation in service of human health. The company is described as an innovative pharmaceutical enterprise that has developed strong research and development capabilities, a quality product structure, and a comprehensive production management system. It positions itself as a specialized player deeply embedded in China's cardiovascular and cerebrovascular drug market.
Sources: Sihuanpharm official site
Sihuanpharm develops, produces, and markets pharmaceutical products, with a specific focus on cardiovascular and cerebrovascular drugs in China. The company operates with a distinctive marketing model and provides specialized services to its customers. It applies its research and development strengths to build a quality product portfolio while maintaining a comprehensive production management system, all guided by a corporate mission of innovating in service of human health.
Sources: Sihuanpharm official site
Sihuanpharm is known for its deep specialization in China's cardiovascular and cerebrovascular drug market. The company has earned broad recognition from society and expert users alike, building a strong reputation through its unique marketing model, professional services, and robust research and development capabilities. Its corporate spirit-centered on dedication, focus, professionalism, and mutual benefit-is also a notable aspect of its identity.
Sources: Sihuanpharm official site
Based on the available information, Sihuanpharm's primary end users are patients with cardiovascular and cerebrovascular diseases. In addition, the company's products and services are directed toward expert users-likely medical professionals, clinicians, and healthcare institutions-as well as the broader public. The company notes it has earned recognition from 'social circles and expert users,' suggesting a dual audience of both clinical professionals and patients.
Sources: Sihuanpharm official site
Ranked closest to Sihuanpharm: Maine Bodyworks (35/100), Asociatia Sanatatii prin Masaj (35/100), Guangjipharm (33/100).
A step up - brands to learn from: Werskincare (56/100), Virtue TCM 醫道閣 (56/100).
Category leader: Dassault Systèmes (95/100).